These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15050735

  • 1. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.
    Huang SP, Chou YH, Wayne Chang WS, Wu MT, Chen YY, Yu CC, Wu TT, Lee YH, Huang JK, Wu WJ, Huang CH.
    Cancer Lett; 2004 Apr 15; 207(1):69-77. PubMed ID: 15050735
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 1998 May 15; 7(5):385-90. PubMed ID: 9610787
    [Abstract] [Full Text] [Related]

  • 3. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T.
    Cancer Res; 2000 Jan 15; 60(2):305-8. PubMed ID: 10667581
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS, Liu X, Schumacher FR, Casey G, Witte JS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 15; 15(12):2549-52. PubMed ID: 17164384
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS, Isaacs SD, Isaacs WB, Bova GS.
    J Urol; 1998 Oct 15; 160(4):1405-9. PubMed ID: 9751364
    [Abstract] [Full Text] [Related]

  • 8. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.
    John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA.
    Cancer Res; 2005 Jun 15; 65(12):5470-9. PubMed ID: 15958597
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT.
    Cancer Epidemiol Biomarkers Prev; 2007 Dec 15; 16(12):2566-71. PubMed ID: 18086759
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, Barricarte A, Berg CD, Bergland G, Bingham S, Brustad M, Bueno-de-Mesquita HB, Burdette L, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Cox DG, Dossus L, Feigelson HS, Haiman CA, Hankinson SE, Hoover RN, Hunter DJ, Husing A, Kaaks R, Kolonel LN, Le Marchand L, Linseisen J, McCarty CA, Overvad K, Panico S, Purdue MP, Stram DO, Stevens VL, Trichopoulos D, Willett WC, Yuenger J, Thun MJ.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):297-305. PubMed ID: 19124512
    [Abstract] [Full Text] [Related]

  • 11. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C.
    J Hum Genet; 2002 Jan 15; 47(8):413-8. PubMed ID: 12181642
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW.
    Cancer Res; 2001 Jun 01; 61(11):4333-6. PubMed ID: 11389055
    [Abstract] [Full Text] [Related]

  • 13. Genetic variants in the vitamin D receptor gene and prostate cancer risk.
    Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 01; 14(4):997-9. PubMed ID: 15824177
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population.
    Malecki MT, Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J.
    Exp Clin Endocrinol Diabetes; 2003 Dec 01; 111(8):505-9. PubMed ID: 14714273
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D receptor gene polymorphisms and breast cancer risk.
    Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, Wilson RG, Thomas V, Colston KW.
    Clin Cancer Res; 2004 Aug 15; 10(16):5472-81. PubMed ID: 15328186
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A.
    Med Sci Monit; 2009 Aug 15; 15(8):BR232-42. PubMed ID: 19644412
    [Abstract] [Full Text] [Related]

  • 17. The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.
    Szendroi A, Speer G, Tabak A, Kosa JP, Nyirady P, Majoros A, Romics I, Lakatos P.
    Can J Urol; 2011 Jun 15; 18(3):5710-6. PubMed ID: 21703046
    [Abstract] [Full Text] [Related]

  • 18. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
    Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK, Huang CH.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 15; 13(12):2217-24. PubMed ID: 15598783
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W, Suzuki Y, Kato K, Tanji S, Konda R, Fujioka T.
    Int J Urol; 2007 Jun 15; 14(6):483-7. PubMed ID: 17593089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.